scispace - formally typeset
R

Robert D. Bruno

Researcher at Old Dominion University

Publications -  35
Citations -  1374

Robert D. Bruno is an academic researcher from Old Dominion University. The author has contributed to research in topics: Progenitor cell & Stem cell. The author has an hindex of 19, co-authored 35 publications receiving 1168 citations. Previous affiliations of Robert D. Bruno include University of Maryland, Baltimore & College of Health Sciences, Bahrain.

Papers
More filters
Journal ArticleDOI

Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

TL;DR: This review offers the first comprehensive analysis of strategies in drug development that either inhibit or exploit CYP enzymes for the treatment of cancer.
Journal ArticleDOI

CYP17 inhibitors for prostate cancer therapy

TL;DR: The role of androgen biosynthesis in the progression of prostate cancer and the impact of CYP17 inhibitors, such as ketoconazole, abiraterone acetate, VN/124-1 (TOK-001) and TAK-700 in the clinic and in clinical development are highlighted.
Journal ArticleDOI

3D bioprinted mammary organoids and tumoroids in human mammary derived ECM hydrogels

TL;DR: A novel mammary-specific culture protocol that combines a self-gelling hydrogel comprised solely of ECM from decellularized rat or human breast tissue with the use of the previously described 3D bioprinting platform is described, providing a suitable platform for ECM and epithelial/cancer cell studies.
Journal ArticleDOI

Reprogramming Human Cancer Cells in the Mouse Mammary Gland

TL;DR: The results show that human embryonal carcinoma-derived progeny interact with mouse mammary cells during mammary gland regeneration and are directed to differentiate into cells that exhibit diverse mammary epithelial cell phenotypes.
Journal ArticleDOI

Accessible bioprinting: adaptation of a low-cost 3D-printer for precise cell placement and stem cell differentiation.

TL;DR: This work designed and 3D printed components for the adaptation of an inexpensive 'off-the-shelf' commercially available 3D printer to circumvent the high-price barrier to entry of conventional bioprinters and demonstrates an accessible open-source 3D bioprinter capable of serving the needs of any laboratory interested in 3D cellular interactions and tissue engineering.